Prucalopride in the treatment of chronic constipation ...
Prucalopride 2 mg significantly improved bowel function in chronic constipation patients from the Asia-Pacific region over 12 weeks, with 33.3% achieving ≥3 spontaneous complete bowel movements per week vs 10.3% on placebo (P < 0.001). It was safe, well-tolerated, with common adverse events being diarrhea, nausea, abdominal pain, and headache.
Reference News
Prucalopride in the treatment of chronic constipation ...
Prucalopride 2 mg significantly improved bowel function in chronic constipation patients from the Asia-Pacific region over 12 weeks, with 33.3% achieving ≥3 spontaneous complete bowel movements per week vs 10.3% on placebo (P < 0.001). It was safe, well-tolerated, with common adverse events being diarrhea, nausea, abdominal pain, and headache.